Introduction to Modeling and Simulation for the Pharma Industry

On August 30, 2019 10:00 (GMT-7)

In this seminar, we introduce some of the areas in which Modeling and Simulation is being used in the Life Sciences industry, particularly in the Pharma/Biotech segment wherein both manufacturing processes and medical devices are of critical importance for companies looking to enhance innovation.

Computational Modeling and Simulation (M&S) is prevalent in many industries such as automotive, aerospace, consumer goods, etc., where its power to optimize the design of products and streamline the development process is well recognized and heavily exploited.

We will survey a range of applications from the Pharma/Biotech industry where M&S usage is fairly mature and widespread, as well as emerging opportunities to harness the technology. We will provide examples of multiphysics simulation in the manufacturing process such as powder compaction, particle mixing, and clean room flows. We will discuss packaging simulations to optimize product integrity under environmental and handling conditions. We also introduce the topic of combination products and focus on drug delivery devices and processes which are becoming increasingly important for therapeutic efficacy and patient satisfaction. Finally, we will present a few novel and emerging technologies such as virtual human modeling, multiscale modeling, machine learning, and uncertainty quantification, which are beginning to transform the overall patient experience and are expected to grow in the future.

About the presenter

Karl D'SOUZA | Director of Life Sciences

With over 20 years in the CAE industry, Karl D’SOUZA has extensive experience in technical consulting, product management, and business development as they pertain to simulation-based solutions for science and technology companies. He is currently Director Life Sciences at Dassault Systemes and is focused on developing and commercializing novel digital health solutions for the medical device, pharma/biotechnology, and clinical care segments of the Life Sciences industry. Karl has a B.Tech in Materials Science and Engineering from IIT Bombay, an MS in Mechanical (Biomedical) Engineering from SUNY Buffalo, and an MBA from Bryant University, and is based in Providence, RI, USA.